Please assess the completion status of the following clinical trial:

Trial Title: Study on the Effects of Sitaxsentan on Airway Remodeling in Patients With Severe Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 50 non smoking (25 on active treatment and 25 on placebo) patients with severe asthmatic patients (age over 18 and less than 70) and irreversible airflow obstruction (FEV1≤ 70% of predicted)~Exclusion Criteria:~* Abnormal liver chemistry at inclusion, female without acceptable contraceptive methods

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- sitaxsentan, airway remodeling (Type: PLACEBO_COMPARATOR): Blinded, randomised placebo-controlled trial involving two parallel groups of severe asthmatic patients with irreversible airflow obstruction (FEV1≤ 70% of predicted) .
- placebo, airway remodeling (Type: PLACEBO_COMPARATOR): Blinded, randomised placebo-controlled trial involving two parallel groups of severe asthmatic patients with irreversible airflow obstruction (FEV1≤ 70% of predicted) .

Based on this trial design, predict the completion outcome and termination type (if applicable).